Showcase

Process Innovations in Pharmaceuticals (PIPMM) – Technology Showcase
Date: 20 March 2025 | Time: 4.00 PM- 6:30 PM (Indian Standard Time) | Online event

The event is free but registration is mandatory

Technology Seekers Register Here | Photos

Contact:

kavita.parekh@venturecenter.co.in

Detailed Outline

Technology Providers

Samir Chikkali

CSIR- National Chemical Laboratory

Dr. Samir H. Chikkali is a Chief Scientist (G) and Professor at the Academy of Scientific and Innovative Research (AcSIR) within the Polymer Science and Engineering Division at CSIR-National Chemical Laboratory (NCL), Pune. He leads the POMCAT (POlymer and OrganoMetallic CATalysis) research group, focusing on catalysis, polymer chemistry, and sustainable chemistry. Dr. Chikkali earned his Ph.D. from the University of Stuttgart, Germany, and pursued postdoctoral research at the University of Amsterdam and the University of Konstanz as an Alexander von Humboldt Fellow. He has published extensively in high-impact journals such as the Journal of the American Chemical Society and Angewandte Chemie. His contributions have been recognized with numerous awards, including the CSIR-NCL Best Scientist Award for 2016–17 and again in 2022–23. Dr. Chikkali serves as an Associate Editor for the Bulletin of Materials Science and is a reviewer for several high-impact journals.

Sanjay P Kamble

CSIR- National Chemical Laboratory

Dr. Sanjay P. Kamble is a Senior Principal Scientist at the CSIR-National Chemical Laboratory (NCL) in Pune, India, with over a decade of research experience. He earned his Ph.D. in Chemical Engineering from the Institute of Chemical Technology (ICT), Mumbai, in 2007, where he also served as a lecturer for two years. His research focuses on process intensification and scale-up, process development, and wastewater treatment using advanced oxidation processes and microalgae for environmental and energy applications. Dr. Kamble has authored over 35 publications in esteemed international journals and holds more than eight national and international patents. His contributions have been recognized with awards such as the CSIR Young Scientist Award (2010), Young Associate of the Maharashtra Academy of Sciences (2010) among others. Notably, he led the development of a cost-effective and environmentally friendly process for paracetamol production, reducing manufacturing costs by 15-20%, which earned the NCL RF-Cipla Hamied Award for the Best Process of the Year in 2019

Ravindra Kontham

CSIR- National Chemical Laboratory

Dr. Ravindar Kontham received his BSc from Kakatiya University, Warangal, India, MSc from Osmania University, Hyderabad, and Ph.D. from the CSIR-Indian Institute of Chemical Technology, Hyderabad, under Dr. J. S. Yadav (former Director, CSIR-IICT) in 2008. He then completed postdoctoral research with Prof. Pierre Deslongchamps at Université de Sherbrooke (2 years) and Université Laval, Québec (3 years). After a 9-month stay at Toronto Research Chemicals, Toronto, he returned to India and joined the Division of Organic Chemistry, CSIR-National Chemical Laboratory, Pune, as a Senior Scientist in September 2014. He is currently a Principal Scientist-CSIR, India, and Associate Professor-AcSIR, India. His research focuses on novel cascade/domino reactions involving main group and transition metal catalysis, total synthesis of bioactive natural products, design and synthesis of new chemical entities for drug discovery, and process development for APIs and intermediates.

Amol Kulkarni

CSIR- National Chemical Laboratory

Dr. Amol A. Kulkarni is a Senior Principal Scientist at the Chemical Engineering & Process Development Division of CSIR-National Chemical Laboratory (NCL), Pune, where he has served since 2005. He holds a Ph.D. in Chemical Engineering (2003) and B. Chem. Eng. (1998) from the Institute of Chemical Technology (ICT), Mumbai. A Humboldt Fellow (2004) at MPI-Magdeburg, Germany, he was also an IUSSTF Research Fellow at MIT, USA (2010). Dr. Kulkarni specializes in microreactors, multiphase reactors, process intensification, and industrial flow processes. He established India’s first microreactor lab and developed the first scalable continuous process for silver nanowires. His accolades include the Shanti Swarup Bhatnagar Prize (2020), Swarnajayanti Fellowship (2015), VASVIK Award (2016), and CSIR Young Scientist Award (2011). With 90+ papers, 35+ patents, and 7 Ph.D. students supervised, he serves on editorial boards of major journals and is a member of international and national scientific committees.

Gautam Panda

CSIR- Central Drug Research Institute

Dr. Gautam Panda is a Chief Scientist in the Medicinal and Process Chemistry Division at CSIR-Central Drug Research Institute (CDRI), Lucknow. He earned his M.Sc. from IIT Kharagpur in 1993 and completed his Ph.D. under Prof. Goverdhan Mehta at the University of Hyderabad in 1999. Following postdoctoral research in Canada and Taiwan, he joined CDRI in 2002. With over 23 years in biomedical research, Dr. Panda specializes in harnessing chiral amino acids and trisubstituted methanes for drug discovery. He has authored approximately 132 publications, holds 12 patents, and has developed cost-effective synthesis routes for drugs like Nintedanib and Olaparib. His work includes the first biomedical application of corannulene-derived amino acids and peptides, and the synthesis of over 20 bioactive natural products and their stereoisomers. Dr. Panda has received accolades such as the Chemical Research Society of India Bronze Medal (2012) and membership in the National Academy of Sciences (2014). He has also established international collaborations, including programs with Hiroshima University and Osaka University in Japan.

Ajay Kumar Srivastava

CSIR- Central Drug Research Institute

Dr. Ajay Kumar Srivastava is a Principal Scientist at CSIR-Central Drug Research Institute (CDRI), Lucknow. He earned his M.Sc. in Chemistry from the University of Delhi and his Ph.D. from Jadavpur University, conducting research at CSIR-CDRI under Dr. Gautam Panda. Following a two-year postdoctoral tenure in chemical biology with Prof. S. B. Park at Seoul National University, South Korea, he served as a Scientist at CSIR-Indian Institute of Chemical Technology, Hyderabad, from August 2011 to March 2017, before joining CSIR-CDRI. Dr. Srivastava’s research focuses on developing novel chemical entities through innovative, scalable, and environmentally friendly chemistry. His expertise encompasses synthetic methodologies, process development, and medicinal chemistry. He has authored 54 research articles and supervised 10 Ph.D. students. Notably, his group transferred the process for Umifenovir to Medizest Pvt. Ltd. for repurposing during the COVID-19 pandemic. Additionally, his team collaborates with Dr. Reddy’s Laboratories and ARKN Pvt. Ltd. on various sponsored projects.